Patents by Inventor Yanning Lin

Yanning Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20230061743
    Abstract: The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
    Type: Application
    Filed: May 27, 2022
    Publication date: March 2, 2023
    Inventors: Eric Joel Benjamin, Wendy Ann Dulin, Yanning Lin, Kai Zhuang
  • Sustained release pharmaceutical compositions
    Patent number: 11179369
    Abstract: The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: November 23, 2021
    Assignee: Wyeth LLC
    Inventors: Eric Joel Benjamin, Wendy Ann Dulin, Yanning Lin, Kai Zhuang
  • SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20200138781
    Abstract: The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
    Type: Application
    Filed: November 1, 2019
    Publication date: May 7, 2020
    Inventors: Eric Joel Benjamin, Wendy Ann Dulin, Yanning Lin, Kai Zhuang
  • Sustained release pharmaceutical compositions
    Patent number: 10463648
    Abstract: The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: November 5, 2019
    Assignee: Wyeth, LLC
    Inventors: Eric Joel Benjamin, Wendy Ann Dulin, Yanning Lin, Kai Zhuang
  • Sustained release pharmaceutical compositions
    Patent number: 10292966
    Abstract: The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: May 21, 2019
    Assignee: Wyeth LLC
    Inventors: Eric J. Benjamin, Wendy A. Dulin, Yanning Lin, Kai Zhuang
  • SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20180344695
    Abstract: The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
    Type: Application
    Filed: August 8, 2018
    Publication date: December 6, 2018
    Inventors: Eric Joel Benjamin, Wendy Ann Dulin, Yanning Lin, Kai Zhuang
  • SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20180193311
    Abstract: The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
    Type: Application
    Filed: March 5, 2018
    Publication date: July 12, 2018
    Inventors: Eric J. Benjamin, Wendy A. Dulin, Yanning Lin, Kai Zhuang
  • Controlled-release formulation of piperazine-piperidine antagonists and agonists of the 5-HT1A receptor having enhanced intestinal dissolution
    Publication number: 20080199518
    Abstract: The present invention relates to controlled-release beads comprising diquinoline-substituted piperazine-piperidine compounds, such as 5-fluoro-8-{4-[4-[(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}quinoline, or pharmaceutically acceptable salts thereof; to multiple particulate formulations comprising such beads; to methods of preparing such beads; and to methods of treating 5-HT1A-related disorders using such beads and/or multiple particulate formulations.
    Type: Application
    Filed: November 27, 2007
    Publication date: August 21, 2008
    Applicant: Wyeth
    Inventors: Mannching Sherry Ku, Wendy Ann Dulin, Yanning Lin
  • Dihydrobenzofuran derivatives and uses therof
    Publication number: 20060258739
    Abstract: The present invention provides a composition comprising a compound of formula I: or a pharmaceutically acceptable salt thereof, wherein each of R1, R2, R3, y, n, and Ar are as defined, and described in classes and subclasses herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. Such compounds, and compositions thereof, are useful for treating a variety of central nervous system disorders such as schizophrenia.
    Type: Application
    Filed: April 21, 2006
    Publication date: November 16, 2006
    Applicant: Wyeth
    Inventors: Jiu Ai, Yanning Lin
  • Formulations of [1,4]diazepino[6,7,1-IJ]quinoline derivatives
    Publication number: 20060110451
    Abstract: The present invention provides solid dosage formulations of [1,4]diazepino[6,7,1-ij]quinoline derivatives and processes for their manufacture. In some particular embodiments, the present invention provides novel formulations of the antipsychotic and antiobesity agent (9aR,12aS)-4,5,6,7,9,9a,10,11,12,12a-decahydrocyclopenta[c][1,4]diazepino[6,7,1-ij]quinoline hydrochloride (Compound A.HCl).
    Type: Application
    Filed: November 4, 2005
    Publication date: May 25, 2006
    Applicant: Wyeth
    Inventors: Yanning Lin, Wendy Dulin, Mannching Ku
  • Sustained release pharmaceutical compositions
    Publication number: 20050095292
    Abstract: The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
    Type: Application
    Filed: October 28, 2004
    Publication date: May 5, 2005
    Applicant: Wyeth
    Inventors: Eric Benjamin, Wendy Dulin, Yanning Lin, Kai Zhuang